<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Rondaxe</title>
	<atom:link href="http://www.rondaxe.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.rondaxe.com</link>
	<description>Guiding you on the drug development path to success</description>
	<lastBuildDate>Tue, 01 May 2012 17:46:11 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Alvarez &amp; Marsal Healthcare Industry Group Forms Strategic Alliance with Rondaxe</title>
		<link>http://www.rondaxe.com/2011/06/15/alvarez-marsal-healthcare-industry-group-forms-strategic-alliance-with-rondaxe/</link>
		<comments>http://www.rondaxe.com/2011/06/15/alvarez-marsal-healthcare-industry-group-forms-strategic-alliance-with-rondaxe/#comments</comments>
		<pubDate>Wed, 15 Jun 2011 18:10:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.rondaxe.com/?p=824</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2011/06/15/alvarez-marsal-healthcare-industry-group-forms-strategic-alliance-with-rondaxe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemical &amp; Engineering News: K. Shultis (Rondaxe) quoted in “CUSTOM CHEMICALS” article</title>
		<link>http://www.rondaxe.com/2011/01/31/chemical-engineering-news-k-shultis-rondaxe-quoted-in-custom-chemicals-article/</link>
		<comments>http://www.rondaxe.com/2011/01/31/chemical-engineering-news-k-shultis-rondaxe-quoted-in-custom-chemicals-article/#comments</comments>
		<pubDate>Mon, 31 Jan 2011 20:49:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.rondaxe.com/?p=689</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2011/01/31/chemical-engineering-news-k-shultis-rondaxe-quoted-in-custom-chemicals-article/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Business Journal Central New York &#8211; Jeff Evans launches drug development company</title>
		<link>http://www.rondaxe.com/2010/10/01/oct-1-2010-business-journal-central-york-jeff-evans-launches-drug-development-company/</link>
		<comments>http://www.rondaxe.com/2010/10/01/oct-1-2010-business-journal-central-york-jeff-evans-launches-drug-development-company/#comments</comments>
		<pubDate>Fri, 01 Oct 2010 20:04:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.rondaxe.com/?p=528</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/10/01/oct-1-2010-business-journal-central-york-jeff-evans-launches-drug-development-company/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rondaxe Enterprises names Kenton Shultis CEO</title>
		<link>http://www.rondaxe.com/2010/10/01/rondaxe-enterprises-names-kenton-shultis-ceo/</link>
		<comments>http://www.rondaxe.com/2010/10/01/rondaxe-enterprises-names-kenton-shultis-ceo/#comments</comments>
		<pubDate>Fri, 01 Oct 2010 14:53:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=521</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/10/01/rondaxe-enterprises-names-kenton-shultis-ceo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FiercePharma Manufacturing: Service Calculates API-making costs for generics</title>
		<link>http://www.rondaxe.com/2010/09/28/fiercepharma-manufacturing-service-calculates-api-making-costs-generics/</link>
		<comments>http://www.rondaxe.com/2010/09/28/fiercepharma-manufacturing-service-calculates-api-making-costs-generics/#comments</comments>
		<pubDate>Tue, 28 Sep 2010 14:47:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=512</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/09/28/fiercepharma-manufacturing-service-calculates-api-making-costs-generics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical Commerce: Thomson Reuters &amp; Rondaxe provide API manufacturing cost estimating</title>
		<link>http://www.rondaxe.com/2010/09/23/pharmaceutical-commerce-thomson-reuters-rondaxe-provide-api-manufacturing-cost-estimating/</link>
		<comments>http://www.rondaxe.com/2010/09/23/pharmaceutical-commerce-thomson-reuters-rondaxe-provide-api-manufacturing-cost-estimating/#comments</comments>
		<pubDate>Thu, 23 Sep 2010 14:44:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=508</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/09/23/pharmaceutical-commerce-thomson-reuters-rondaxe-provide-api-manufacturing-cost-estimating/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Generic Drug Sector Gets Better Information on API Manufacturing Costs from Thomson Reuters and Rondaxe Enterprises</title>
		<link>http://www.rondaxe.com/2010/09/01/generic-drug-sector-gets-better-information-on-api-manufacturing-costs-from-thomson-reuters-and-rondaxe-enterprises/</link>
		<comments>http://www.rondaxe.com/2010/09/01/generic-drug-sector-gets-better-information-on-api-manufacturing-costs-from-thomson-reuters-and-rondaxe-enterprises/#comments</comments>
		<pubDate>Wed, 01 Sep 2010 00:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=348</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/09/01/generic-drug-sector-gets-better-information-on-api-manufacturing-costs-from-thomson-reuters-and-rondaxe-enterprises/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FTC appoints Karl L. Hoffman of Rondaxe Pharma to oversee Novartis  asset transfer and order compliance</title>
		<link>http://www.rondaxe.com/2010/08/16/ftc-appoints-karl-l-hoffman-of-rondaxe-pharma-to-oversee-novartis-asset-transfer-and-order-compliance/</link>
		<comments>http://www.rondaxe.com/2010/08/16/ftc-appoints-karl-l-hoffman-of-rondaxe-pharma-to-oversee-novartis-asset-transfer-and-order-compliance/#comments</comments>
		<pubDate>Mon, 16 Aug 2010 00:00:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=352</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/08/16/ftc-appoints-karl-l-hoffman-of-rondaxe-pharma-to-oversee-novartis-asset-transfer-and-order-compliance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rondaxe and TD2 form strategic drug development alliance</title>
		<link>http://www.rondaxe.com/2010/02/18/rondaxe-and-td2-form-strategic-drug-development-alliance/</link>
		<comments>http://www.rondaxe.com/2010/02/18/rondaxe-and-td2-form-strategic-drug-development-alliance/#comments</comments>
		<pubDate>Thu, 18 Feb 2010 00:00:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=357</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2010/02/18/rondaxe-and-td2-form-strategic-drug-development-alliance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rondaxe Cost of Goods Software cited in leading industry publication</title>
		<link>http://www.rondaxe.com/2009/09/01/rondaxe-cost-of-goods-software-cited-in-leading-industry-publication/</link>
		<comments>http://www.rondaxe.com/2009/09/01/rondaxe-cost-of-goods-software-cited-in-leading-industry-publication/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 00:00:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://devlog.rondaxe.net/wordpress/?p=354</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.rondaxe.com/2009/09/01/rondaxe-cost-of-goods-software-cited-in-leading-industry-publication/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

